Cite
Arellano J, González JM, Qian Y, et al. Physician preferences for bone metastasis drug therapy in Canada. Curr Oncol. 2015;22(5):e342-8doi: 10.3747/co.22.2380.
Arellano, J., González, J. M., Qian, Y., Habib, M., Mohamed, A. F., Gatta, F., Hauber, A. B., Posner, J., Califaretti, N., & Chow, E. (2015). Physician preferences for bone metastasis drug therapy in Canada. Current oncology (Toronto, Ont.), 22(5), e342-8. https://doi.org/10.3747/co.22.2380
Arellano, J, et al. "Physician preferences for bone metastasis drug therapy in Canada." Current oncology (Toronto, Ont.) vol. 22,5 (2015): e342-8. doi: https://doi.org/10.3747/co.22.2380
Arellano J, González JM, Qian Y, Habib M, Mohamed AF, Gatta F, Hauber AB, Posner J, Califaretti N, Chow E. Physician preferences for bone metastasis drug therapy in Canada. Curr Oncol. 2015 Oct;22(5):e342-8. doi: 10.3747/co.22.2380. PMID: 26628874; PMCID: PMC4608407.
Copy
Download .nbib